Anti-CD112R compositions and methods
US11279758B2 · kind B2 · utility
1Cited by
31References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 19, 2019 |
| Grant date | Mar 22, 2022 |
| Priority date | — |
| Expiry date | Sep 4, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides anti-CD112R antibody compositions and their use in treating cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.